Objective To research the effects of short-term intensive insulin treatment on regaining the sensitivity of sulfonylureas in diabetes patients.

Prof Bloomgarden: Another effect of the incretin-based therapies would simply be to allow patients to not use sulfonylureas.

Pioglitazone was tested in combination with a sulfonylurea, insulin, or metformin in 8 trials (8501 patients).